Comparison of treatment alternatives in Parkinson's disease with best-wordt scaling, time trade-off and visual analogue scales by Weernink, Marieke G.M. et al.
Comparison of Treatment Alternatives in Parkinson’s Disease with 
Best-Worst Scaling, Time Trade-Off and Visual Analogue Scales 
University Twente, Health Technology & Services Research, MIRA institute for Biomedical Technology and Technical Medicine, Enschede 
Marieke G.M. Weernink, Karin G.M. Groothuis-Oudshoorn, Maarten J. IJzerman, Janine A. van Til  
• The ability to determine the utility of the process of care  
would benefit estimation of cost-effectiveness.  
• Visual Analogue Scales (VAS) and Time Trade Off (TTO) 
are thought to be insensitive to small differences in 
process and outcome of care. 
• Best-Worst scaling (BWS) was proposed as a sensitive 
and valid method to generate utilities.  
• As BWS estimates utilities on a latent scale, a key challenge is 
the anchoring of values to the health utility scale.  
• We propose to anchor indirect elicited BWS utility weights 
into traditional health state utilities on the QALY scale (0-1) 
and derive a functional form. 
Table 2 : Paired t-test results of comparison of mean treatment profiles 
 
 
1) What is the agreement in utility estimates with BWS, VAS 
and TTO of six different treatment alternatives? (validity) 
 
1) To what extent are BWS, VAS and TTO estimates able 
(sensitive) to differentiate between the utility of the six 
different treatment alternatives?  
Table 1: Mean utility scores of four methods 
Background Research Questions 
Methods 
Discussion 
 
• Public sample of 596 respondents (online 
survey) 
• Valuation of six treatment profiles in 
Parkinson’s Disease using TTO and VAS.  
• BWS2 and BWS3 choice questions,  
following a D-efficient design  result in 
BWS utility weights for same six treatment 
profiles.  
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Attribute 
suffer from: 
Worst  
profile 
Profile 1 Profile 2 Profile 3 Profile 4 
Best  
profile 
Tremors Often Often Seldom  Seldom  Sometimes Seldom  
Posture and 
balance problems 
Often Seldom Seldom  Often Sometimes Seldom  
Slowness of motion Often Seldom Seldom  Often Sometimes Seldom 
Dizziness Often Often Often Seldom  Seldom  Seldom 
Drowsiness Often Sometimes Often Often Seldom Seldom 
Dyskinesia Often Often Often Seldom Seldom Seldom  
Mode of 
administration 
Brain surgery Tablets Tablets Tablets Tablets Tablets 
Despite scaling differences, there is no statistical significant 
difference in BWS, TTO or VAS utility values; each of the mean-
utility scores follows a monotonic relationship (table 1) and the 
correlation across-respondents means was very strong for all 
methods (VAS-BWS2 .985; VAS-BWS3 0.989; TTO-BWS2 0.987; 
TTO-BWS3 0.987, BWS2-BWS3 0.989; P<0.000, n=422).  
Mean comparison of df BWS2 BWS3 VAS TTO 
Worst – Best 421 P< 0.000 P< 0.000 P< 0.000 P< 0.000 
Worst – profile 1 203 P< 0.000 P< 0.000 P< 0.000 P< 0.000 
profile 1 – profile 2 69 P< 0.000 P< 0.000 P< 0.000 
t = 1.931, 
P 0.029 
profile 2 – profile 3 63 P< 0.000 P< 0.000 
t = 0.509, 
P 0.306 
t =1.107, 
P 0.136 
profile 3 – profile 4 72 P< 0.000 P< 0.000 P< 0.000 
t = 2.005, 
P 0.024 
profile 4 – Best 214 P< 0.000 P< 0.000 P< 0.000 P< 0.000 
Treatment profile BWS2 BWS3 VAS TTO 
Worst -4.32 -1.46 .25 .34 
Profile 1 13.42 2.31 .48 .59 
Profile 2 17.53 2.85 .53 .69 
Profile 3 20.28 3.32 .55 .77 
Profile 4 24.03 5.25 .65 .88 
Best 30.26 6.00 .78 .93 
Results 
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- Profile 4  Best Profile  
- Profile 1  Profile 4  
- Worst Profile  Profile 1 
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Both BWS methods are able to differentiate between all six 
treatment profiles, VAS and TTO are less sensitive (table 2).  
All methods use different parts of their own scale to value 
treatment profiles.  
Figure 2: Distribution of a 
methods scale to discriminate 
between treatment profiles 
Figure 1: Scatterplot of mean-utility scores 
                                                                                                                                                                                                                           
